0001593968-19-001276.txt : 20190604 0001593968-19-001276.hdr.sgml : 20190604 20190604130010 ACCESSION NUMBER: 0001593968-19-001276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190601 FILED AS OF DATE: 20190604 DATE AS OF CHANGE: 20190604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kunz Barbara Lopez CENTRAL INDEX KEY: 0001679970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 19875885 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2019-06-01 0001671584 Aptevo Therapeutics Inc. APVO 0001679970 Kunz Barbara Lopez 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 true false false false Board of Directors Option (right to buy) 0.7250 2019-06-01 4 A false 25000 0 A 2020-06-01 2029-06-01 Aptevo Therapeutics Inc. common stock 25000 25000 D The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020. /s/ Kunz, Barbara Lopez 2019-06-04